Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome
- PMID: 1993944
- DOI: 10.1016/s0022-3476(05)80482-2
Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome
Abstract
We examined 61 patients an average of 9.6 years (range 5 to 18 years) after an episode of childhood hemolytic-uremic syndrome. Twenty-four (39%) had one or more abnormalities. Seven (11%) had proteinuria and six (10%) had low creatinine clearance as solitary abnormalities. Eight (13%) had both proteinuria and reduced creatinine clearance; three (5%) had a combination of hypertension, proteinuria, and low creatinine clearance. Abnormalities sometimes appeared after an interval of apparent recovery. Logistic regression analysis showed that duration of anuria was the best predictor of disease at follow-up. No patients who had anuria lasting longer than 8 days or oliguria exceeding 15 days escaped chronic disease. However, 45% of those with disease had no anuria, and a third had no oliguria. Physicians should therefore be cautious in assuming recovery from HUS on the basis of a single evaluation and should periodically evaluate patients for an extended period.
Comment in
-
Proteinuria and prognosis in hemolytic-uremic syndrome.J Pediatr. 1991 Nov;119(5):841-2. doi: 10.1016/s0022-3476(05)80319-1. J Pediatr. 1991. PMID: 1941399 No abstract available.
Similar articles
-
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9. Pediatr Nephrol. 2008. PMID: 18465151
-
Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features.Pediatr Nephrol. 1997 Apr;11(2):156-60. doi: 10.1007/s004670050248. Pediatr Nephrol. 1997. PMID: 9090653 Clinical Trial.
-
Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome.Am J Nephrol. 1993;13(3):194-7. doi: 10.1159/000168617. Am J Nephrol. 1993. PMID: 8213930
-
Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome.Yale J Biol Med. 1994 Jan-Apr;67(1-2):1-14. Yale J Biol Med. 1994. PMID: 7645308 Free PMC article. Review.
-
[Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].Arch Pediatr. 2011 Jul;18(7):823-30. doi: 10.1016/j.arcped.2011.04.001. Epub 2011 May 14. Arch Pediatr. 2011. PMID: 21571510 Review. French.
Cited by
-
Long-term kidney outcomes in non-dialyzed children with Shiga-toxin Escherichia coli associated hemolytic uremic syndrome.Pediatr Nephrol. 2023 Jul;38(7):2131-2136. doi: 10.1007/s00467-022-05851-4. Epub 2023 Jan 3. Pediatr Nephrol. 2023. PMID: 36595068
-
Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.Pediatr Nephrol. 2011 Aug;26(8):1247-54. doi: 10.1007/s00467-011-1867-0. Epub 2011 Apr 30. Pediatr Nephrol. 2011. PMID: 21533629 Clinical Trial.
-
Enterohemorrhagic colitis with disseminated intravascular coagulation.Proc (Bayl Univ Med Cent). 2018 May 14;31(3):319-320. doi: 10.1080/08998280.2018.1463776. eCollection 2018 Jul. Proc (Bayl Univ Med Cent). 2018. PMID: 29904297 Free PMC article.
-
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067. Toxins (Basel). 2020. PMID: 31973203 Free PMC article. Review.
-
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0059823. doi: 10.1128/aac.00598-23. Epub 2023 Dec 4. Antimicrob Agents Chemother. 2024. PMID: 38047751 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources